Table of Contents Author Guidelines Submit a Manuscript
Advances in Orthopedics
Volume 2015, Article ID 138382, 7 pages
http://dx.doi.org/10.1155/2015/138382
Clinical Study

Long Term Anticoagulation (4–16 Years) Stops Progression of Idiopathic Hip Osteonecrosis Associated with Familial Thrombophilia

1The Cholesterol, Metabolism, and Thrombosis Center, Jewish Hospital of Cincinnati, Cincinnati, OH 45207, USA
2The Department of Orthopedic Surgery, Cincinnati VA Hospital, Cincinnati, OH 45207, USA
3The Department of Radiology, College of Medicine, University of Cincinnati, Cincinnati, OH 45207, USA

Received 22 August 2014; Accepted 23 December 2014

Academic Editor: Rene C. Verdonk

Copyright © 2015 Charles J. Glueck et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Ficat, “Cortisone associated necrosis of bone,” in Ischemia and Necrosis of Bone, D. Hungerford, Ed., pp. 171–176, Williams and Wilkins, Baltimore, Md, USA, 1980. View at Google Scholar
  2. C. J. Glueck, R. A. Freiberg, and P. Wang, “Treatment of osteonecrosis of the hip and knee with enoxaparin,” in Osteonecrosis, K. H. Koh, Ed., pp. 241–247, Springer, Berlin, Germany, 2014. View at Publisher · View at Google Scholar
  3. P. Orth and K. Anagnostakos, “Coagulation abnormalities in osteonecrosis and bone marrow edema syndrome,” Orthopedics, vol. 36, no. 4, pp. 290–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Glueck, N. Goldenberg, S. Budhani et al., “Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia,” Translational Research, vol. 158, no. 4, pp. 225–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. Boss and I. Misselevich, “Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals,” Veterinary Pathology, vol. 40, no. 4, pp. 345–354, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Björkman, I. M. Burtscher, P. J. Svensson, A. Hillarp, J. Besjakov, and G. Benoni, “Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee,” Archives of Orthopaedic and Trauma Surgery, vol. 125, no. 1, pp. 51–55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Björkman, P. J. Svensson, A. Hillarp, I. M. Burtscher, A. Rünow, and G. Benoni, “Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults,” Clinical Orthopaedics and Related Research, no. 425, pp. 168–172, 2004. View at Google Scholar · View at Scopus
  8. V. V. Balasa, R. A. Gruppo, C. J. Glueck et al., “Legg-Calvé-Perthes disease and thrombophilia,” Journal of Bone and Joint Surgery, vol. 86, no. 12, pp. 2642–2647, 2004. View at Google Scholar · View at Scopus
  9. C. J. Glueck, R. A. Freiberg, G. Boriel et al., “The role of the factor V Leiden mutation in osteonecrosis of the hip,” Clinical and Applied Thrombosis/Hemostasis, vol. 19, no. 5, pp. 499–503, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. J. Glueck, R. A. Freiberg, S. Boppana, and P. Wang, “Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis,” Journal of Bone and Joint Surgery, vol. 90, no. 10, pp. 2220–2229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Glueck, R. A. Freiberg, L. Sieve, and P. Wang, “Enoxaparin prevents progression of stages I and II osteonecrosis of the hip,” Clinical Orthopaedics and Related Research, no. 435, pp. 164–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Wåhlander, G. Larson, T. L. Lindahl et al., “Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery,” Thrombosis and Haemostasis, vol. 87, no. 4, pp. 580–585, 2002. View at Google Scholar · View at Scopus
  13. S. Hofmann and B. Mazières, “Osteonecrosis: natural course and conservative therapy,” Orthopade, vol. 29, no. 5, pp. 403–410, 2000. View at Google Scholar · View at Scopus
  14. T. Chotanaphuti, S. Thongprasert, and A. Laoruengthana, “Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip,” Journal of the Medical Association of Thailand, vol. 96, no. 10, pp. 1326–1330, 2013. View at Google Scholar · View at Scopus
  15. D. Williamson, K. Brown, R. Luddington, C. Baglin, and T. Baglin, “Factor V Cambridge: a new mutation (Arg306Thr) associated with resistance to activated protein C,” Blood, vol. 91, no. 4, pp. 1140–1144, 1998. View at Google Scholar
  16. C. J. Glueck, H. I. Glueck, T. Tracy, J. Speirs, C. McCray, and D. Stroop, “Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer,” Metabolism, vol. 42, no. 2, pp. 236–246, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. V. V. Balasa, R. A. Gruppo, C. J. Glueck et al., “The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults,” Thrombosis and Haemostasis, vol. 81, no. 5, pp. 739–744, 1999. View at Google Scholar · View at Scopus
  18. C. J. Glueck, P. Wang, H. Bell, V. Rangaraj, and N. Goldenberg, “Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion,” Clinical and Applied Thrombosis/Hemostasis, vol. 11, no. 4, pp. 375–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. J. Glueck, J. Pranikoff, D. Aregawi et al., “The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage,” Metabolism, vol. 54, no. 10, pp. 1345–1349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. J. Glueck, R. A. Freiberg, R. N. Fontaine, T. Tracy, and P. Wang, “Hypofibrinolysis, thrombophilia, osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 386, pp. 19–33, 2001. View at Google Scholar
  21. K.-H. Koo, R. Kim, G.-H. Ko, H.-R. Song, S.-T. Jeong, and S.-H. Cho, “Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression,” The Journal of Bone & Joint Surgery B, vol. 77, no. 6, pp. 870–874, 1995. View at Google Scholar · View at Scopus
  22. B. N. Stulberg, A. W. Davis, T. W. Bauer, M. Levine, and K. Easley, “Osteonecrosis of the femoral head. A prospective randomized treatment protocol,” Clinical Orthopaedics and Related Research, no. 268, pp. 140–151, 1991. View at Google Scholar · View at Scopus
  23. M. A. Mont, M. G. Zywiel, D. R. Marker, M. S. McGrath, and R. E. Delanois, “The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review,” The Journal of Bone & Joint Surgery A, vol. 92, no. 12, pp. 2165–2170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Kang, K. H. Moon, D. G. Kwon, B. K. Shin, and M. S. Woo, “The natural history of asymptomatic osteonecrosis of the femoral head,” International orthopaedics, vol. 37, no. 3, pp. 379–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. K. Sen, S. K. Tripathy, S. Aggarwal, N. Marwaha, R. R. Sharma, and N. Khandelwal, “Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study,” The Journal of Arthroplasty, vol. 27, no. 5, pp. 679–686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Rastogi, S. R. Sankineani, H. L. Nag et al., “Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study,” Musculoskeletal Surgery, vol. 97, no. 3, pp. 223–228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Rackwitz, L. Eden, S. Reppenhagen et al., “Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head,” Stem Cell Research & Therapy, vol. 3, article 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Hernigou and F. Beaujean, “Treatment of osteonecrosis with autologous bone marrow grafting,” Clinical Orthopaedics and Related Research, no. 405, pp. 14–23, 2002. View at Google Scholar · View at Scopus
  29. D. R. Marker, T. M. Seyler, S. D. Ulrich, S. Srivastava, and M. A. Mont, “Do modern techniques improve core decompression outcomes for hip osteonecrosis?” Clinical Orthopaedics and Related Research, vol. 466, no. 5, pp. 1093–1103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. N. Malizos, A. H. Karantanas, S. E. Varitimidis, Z. H. Dailiana, K. Bargiotas, and T. Maris, “Osteonecrosis of the femoral head: etiology, imaging and treatment,” European Journal of Radiology, vol. 63, no. 1, pp. 16–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Pierre-Jacques, C. J. Glueck, M. A. Mont, and D. S. Hungerford, “Familial heterozygous protein-S deficiency in a patient who had multifocal osteonecrosis. A case report,” Journal of Bone and Joint Surgery, vol. 79, no. 7, pp. 1079–1084, 1997. View at Google Scholar · View at Scopus
  32. C. J. Glueck, R. A. Freiberg, and P. Wang, “Detecting thrombophilia, hypofibrinolysis, and reduced nitric oxide production in osteonecrosis,” Seminars in Arthroplasty, vol. 18, no. 3, pp. 184–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Zalavras, Z. Dailiana, M. Elisaf et al., “Potential aetiological factors concerning the development of osteonecrosis of the femoral head,” European Journal of Clinical Investigation, vol. 30, no. 3, pp. 215–221, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. L. C. Jones, M. A. Mont, T. B. Le et al., “Procoagulants and osteonecrosis,” The Journal of Rheumatology, vol. 30, no. 4, pp. 783–791, 2003. View at Google Scholar · View at Scopus
  35. K. H. Koo, R. Kim, S. H. Cho, H. R. Song, G. Lee, and G. H. Ko, “Angiography, scintigraphy, intraosseous pressure, and histologic findings in high-risk osteonecrotic femoral heads with negative magnetic resonance images,” Clinical Orthopaedics and Related Research, no. 308, pp. 127–138, 1994. View at Google Scholar
  36. A. V. Korompilias, T. L. Ortel, and J. R. Urbaniak, “Coagulation abnormalities in patients with hip osteonecrosis,” Orthopedic Clinics of North America, vol. 35, no. 3, pp. 265–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. I. M. Nilsson, H. Krook, N. H. Sternby, E. Soderberg, and N. Soderstrom, “Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system,” Acta Medica Scandinavica, vol. 169, pp. 323–337, 1961. View at Google Scholar · View at Scopus